» Articles » PMID: 10498490

A Mechanism of Central Sleep Apnea in Patients with Heart Failure

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1999 Sep 25
PMID 10498490
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Breathing is controlled by a negative-feedback system in which an increase in the partial pressure of arterial carbon dioxide stimulates breathing and a decrease inhibits it. Although enhanced sensitivity to carbon dioxide helps maintain the partial pressure of arterial carbon dioxide within a narrow range during waking hours, in some persons a large hyperventilatory response during sleep may lower the value below the apneic threshold, thereby resulting in central apnea. I tested the hypothesis that enhanced sensitivity to carbon dioxide contributes to the development of central sleep apnea in some patients with heart failure.

Methods: This prospective study included 20 men who had treated, stable heart failure with left ventricular systolic dysfunction. Ten had central sleep apnea, and 10 did not. The patients underwent polysomnography and studies of their ventilatory response to carbon dioxide.

Results: Patients who met the criteria for central sleep apnea had significantly more episodes of central apnea per hour than those without central sleep apnea (mean [+/-SD], 35+/-24 vs. 0.5+/-1.0 episodes per hour). Those with sleep apnea also had a significantly larger ventilatory response to carbon dioxide than those without central sleep apnea (5.1+/-3.1 vs. 2.1+/-1.0 liters per minute per millimeter of mercury, P=0.007), and there was a significant positive correlation between ventilatory response and the number of episodes of apnea and hypopnea per hour during sleep (r=0.6, P=0.01).

Conclusions: Enhanced sensitivity to carbon dioxide may predispose some patients with heart failure to the development of central sleep apnea.

Citing Articles

Central sleep apnoea: not just one phenotype.

Randerath W, Baillieul S, Tamisier R Eur Respir Rev. 2024; 33(171).

PMID: 38537948 PMC: 10966472. DOI: 10.1183/16000617.0141-2023.


A call for precision medicine: Facing the challenge of sleep-disordered breathing in heart failure.

Parthasarathy S, Arzt M, Javaheri S Sleep Med. 2023; 112:129-131.

PMID: 37844544 PMC: 10872392. DOI: 10.1016/j.sleep.2023.10.002.


Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases.

Giannoni A, Borrelli C, Gentile F, Sciarrone P, Spiesshofer J, Piepoli M Eur J Heart Fail. 2023; 25(5):642-656.

PMID: 36907827 PMC: 10989193. DOI: 10.1002/ejhf.2819.


Common Co-Morbidities in Heart Failure - Diabetes, Functional Mitral Regurgitation and Sleep Apnoea.

Coats A Int J Heart Fail. 2022; 1(1):25-41.

PMID: 36262740 PMC: 9536668. DOI: 10.36628/ijhf.2019.0004.


International Consensus Statement on Obstructive Sleep Apnea.

Chang J, Goldberg A, Alt J, Mohammed A, Ashbrook L, Auckley D Int Forum Allergy Rhinol. 2022; 13(7):1061-1482.

PMID: 36068685 PMC: 10359192. DOI: 10.1002/alr.23079.